Assessing Acute Side Effects in Hodgkin's Lymphoma Patients Undergoing Radiation Therapy: A Comparison of Sequential and Non-Sequential RT Approaches

M. Hina , M. Tariq , F. Shakeel , S. Arif , Y. Ahmed , S. Abrar , A. Hafiz , N. Ali , A. Abbasi , B. Qureshi
{"title":"Assessing Acute Side Effects in Hodgkin's Lymphoma Patients Undergoing Radiation Therapy: A Comparison of Sequential and Non-Sequential RT Approaches","authors":"M. Hina ,&nbsp;M. Tariq ,&nbsp;F. Shakeel ,&nbsp;S. Arif ,&nbsp;Y. Ahmed ,&nbsp;S. Abrar ,&nbsp;A. Hafiz ,&nbsp;N. Ali ,&nbsp;A. Abbasi ,&nbsp;B. Qureshi","doi":"10.1016/j.ijrobp.2024.11.038","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>To assess acute effects in radiation therapy (RT) for Hodgkin's Lymphoma (HL) after chemotherapy.</div></div><div><h3>Method</h3><div>HL patients treated from March 2017-January 2024 were retrospectively analyzed. Complete data for 63 out of an initial cohort of 100 patients was identified via a comprehensive review of treatment files and online database. Demographic, RT details along with acute effect profile was recorded.</div></div><div><h3>Result</h3><div>Among patients, 44.4%(n=28) were &lt;10 years, 42.9%(n=27) 10-15 years and 12.7%(n=8) &gt;15 years. Males constituted 77.8%(n=49) and females 22.2%(n=14). There were 3.2%(n=2) Stage I, 33.3%(n=21) Stage II, 38.1%(n=24) Stage III, 25.4%(n=16) Stage IV and 22.2%(n=18) Relapsed/Refractory cases.</div><div>RT included 3D-Conformal Radiation Therapy (3DCRT; 23.8%, n=15) and Intensity Modulated Radiation Therapy/Volumetric Modulated Arc Therapy (IMRT/VMAT; 76.2%, n=48) with a median dose of 2980 cGY in 42.9%(n=27). Sites were categorized into supradiaphragmatic only 30.2%(n=19), concurrent 60.3%(n=38), and infradiaphragmatic only 9.5%(n=6). Frequently treated sites included cervical region (88.95%, n=55), mediastinum (65.1%, n=41), para-aortic (58.7%, n=37), spleen (41.3%, n=26), axilla (39.7%, n=25), inguinal (17.5%, n=11), pelvis (14.3%, n=9) and skeletal region (9.5%, n=6). Among patients with both supra and infra diaphragmatic disease, 74.6% (n=47) received concurrent RT to both regions. Sequential RT for either lesion was done in 25.4% (n=16) patients. The majority (66.7%, n=42) experienced no treatment gaps.</div><div>In sequential RT, 11%(n=7) reported no acute effects, 6.3%(n=4) G1 mucositis, 1.6%(n=1) dysphagia and G1 dermatitis each. In non-sequential RT, 38.1%(n=24) reported no acute effects, 22.2%(n=14) G1 dermatitis, 17.5%(n=11) dysphagia, 11.1%(n=7) G1 mucositis and G2 mucositis each, 9.5%(n=6) vomiting, 7.9%(n=5) nausea, 4.8%(n=3) G2 dermatitis, 1.6%(n=1) G3 mucositis and nodal swelling each.</div></div><div><h3>Conclusion</h3><div>Our study highlights the reduced incidence of acute effects with the introduction of conformal RT techniques. Even among those receiving concurrent supra and infra diaphragmatic RT, majority experienced no acute effects, and those who did, tolerated them well.</div></div>","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":"121 3","pages":"Page e10"},"PeriodicalIF":6.4000,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Radiation Oncology Biology Physics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0360301624036125","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

To assess acute effects in radiation therapy (RT) for Hodgkin's Lymphoma (HL) after chemotherapy.

Method

HL patients treated from March 2017-January 2024 were retrospectively analyzed. Complete data for 63 out of an initial cohort of 100 patients was identified via a comprehensive review of treatment files and online database. Demographic, RT details along with acute effect profile was recorded.

Result

Among patients, 44.4%(n=28) were <10 years, 42.9%(n=27) 10-15 years and 12.7%(n=8) >15 years. Males constituted 77.8%(n=49) and females 22.2%(n=14). There were 3.2%(n=2) Stage I, 33.3%(n=21) Stage II, 38.1%(n=24) Stage III, 25.4%(n=16) Stage IV and 22.2%(n=18) Relapsed/Refractory cases.
RT included 3D-Conformal Radiation Therapy (3DCRT; 23.8%, n=15) and Intensity Modulated Radiation Therapy/Volumetric Modulated Arc Therapy (IMRT/VMAT; 76.2%, n=48) with a median dose of 2980 cGY in 42.9%(n=27). Sites were categorized into supradiaphragmatic only 30.2%(n=19), concurrent 60.3%(n=38), and infradiaphragmatic only 9.5%(n=6). Frequently treated sites included cervical region (88.95%, n=55), mediastinum (65.1%, n=41), para-aortic (58.7%, n=37), spleen (41.3%, n=26), axilla (39.7%, n=25), inguinal (17.5%, n=11), pelvis (14.3%, n=9) and skeletal region (9.5%, n=6). Among patients with both supra and infra diaphragmatic disease, 74.6% (n=47) received concurrent RT to both regions. Sequential RT for either lesion was done in 25.4% (n=16) patients. The majority (66.7%, n=42) experienced no treatment gaps.
In sequential RT, 11%(n=7) reported no acute effects, 6.3%(n=4) G1 mucositis, 1.6%(n=1) dysphagia and G1 dermatitis each. In non-sequential RT, 38.1%(n=24) reported no acute effects, 22.2%(n=14) G1 dermatitis, 17.5%(n=11) dysphagia, 11.1%(n=7) G1 mucositis and G2 mucositis each, 9.5%(n=6) vomiting, 7.9%(n=5) nausea, 4.8%(n=3) G2 dermatitis, 1.6%(n=1) G3 mucositis and nodal swelling each.

Conclusion

Our study highlights the reduced incidence of acute effects with the introduction of conformal RT techniques. Even among those receiving concurrent supra and infra diaphragmatic RT, majority experienced no acute effects, and those who did, tolerated them well.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
11.00
自引率
7.10%
发文量
2538
审稿时长
6.6 weeks
期刊介绍: International Journal of Radiation Oncology • Biology • Physics (IJROBP), known in the field as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both education and health policy as it relates to the field. This journal has a particular interest in original contributions of the following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying cancer and normal tissue radiation response.
期刊最新文献
Moving from the background towards the spotlight: A critical review of radiation therapy for locally advanced pancreas cancer. A Pilot Study of CT Simulator Downtime at an African Cancer Conference: Survey Results from AORTIC 2023. Regional Near-surface Dose Predicts Moist Desquamation and Implant Failure in Patients Receiving Radiation Therapy for Breast Cancer. Boswellia serrata for cerebral radiation necrosis after radiosurgery for brain metastases. Development and validation of a prediction model for cardiac events in patients with hepatocellular carcinoma undergoing stereotactic body radiation therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1